Cargando…

Lowered fasting chenodeoxycholic acid correlated with the decrease of fibroblast growth factor 19 in Chinese subjects with impaired fasting glucose

The gut-derived hormone Fibroblast growth factor 19 (FGF19) could regulate glucose metabolism and is induced by bile acids (BAs) through activating Farnesoid X Receptor (FXR). FGF19 was found to decrease in subjects with isolated-impaired fasting glucose (I-IFG) and type 2 diabetes mellitus (T2DM)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jing, Li, Huating, Zhou, Hu, Fang, Li, Xu, Jingjing, Yan, Han, Chen, Shuqin, Song, Qianqian, Zhang, Yinan, Xu, Aimin, Fang, Qichen, Ye, Yang, Jia, Weiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519593/ https://www.ncbi.nlm.nih.gov/pubmed/28729691 http://dx.doi.org/10.1038/s41598-017-06252-6

Ejemplares similares

Serum Fibroblast Growth Factor 19 Levels Are Decreased in Chinese Subjects With Impaired Fasting Glucose and Inversely Associated With Fasting Plasma Glucose Levels
por: Fang, Qichen, et al.
Publicado: (2013)

Identification of Sp1 as a Transcription Activator to Regulate Fibroblast Growth Factor 21 Gene Expression
por: Chen, Shuqin, et al.
Publicado: (2017)

Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat
por: Li, Huating, et al.
Publicado: (2018)

Fasting plasma chenodeoxycholic acid and cholic acid concentrations are inversely correlated with insulin sensitivity in adults
por: Cariou, Bertrand, et al.
Publicado: (2011)

The effects of yam gruel on lowering fasted blood glucose in T2DM rats
por: Lin, Xinjun, et al.
Publicado: (2020)

Decreased Abundance of Akkermansia muciniphila Leads to the Impairment of Insulin Secretion and Glucose Homeostasis in Lean Type 2 Diabetes
por: Zhang, Jing, et al.
Publicado: (2021)

Fibroblast Growth Factor 21 is Related to Atherosclerosis Independent of Nonalcoholic Fatty Liver Disease and Predicts Atherosclerotic Cardiovascular Events
por: Wu, Liang, et al.
Publicado: (2020)

Sodium Butyrate Stimulates Expression of Fibroblast Growth Factor 21 in Liver by Inhibition of Histone Deacetylase 3
por: Li, Huating, et al.
Publicado: (2012)

Bifidobacterium adolescentis Alleviates Liver Steatosis and Steatohepatitis by Increasing Fibroblast Growth Factor 21 Sensitivity
por: Long, Xiaoxue, et al.
Publicado: (2021)

Complementary Role of Fibroblast Growth Factor 21 and Cytokeratin 18 in Monitoring the Different Stages of Nonalcoholic Fatty Liver Disease
por: Wu, Guangyu, et al.
Publicado: (2017)

Synergistic Inhibition of MRSA by Chenodeoxycholic Acid and Carbapenem Antibiotics
por: Cui, Kaiyu, et al.
Publicado: (2022)

Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related Diseases
por: Wu, Liang, et al.
Publicado: (2017)

Gallstone Decalcification and Dissolution Using Chenodeoxycholate and Citrate
por: Sali, Avni, et al.
Publicado: (1990)

Fasting plasma glucose levels and coronary artery calcification in subjects with impaired fasting glucose
por: Eun, Young-Mi, et al.
Publicado: (2016)

Metabolic phenotypes and the gut microbiota in response to dietary resistant starch type 2 in normal-weight subjects: a randomized crossover trial
por: Zhang, Lei, et al.
Publicado: (2019)

Therapeutic Effect of Chenodeoxycholic Acid in an Experimental Rabbit Model of Osteoarthritis
por: Yan, Zhao-wei, et al.
Publicado: (2015)

Chenodeoxycholic Acid Modulates Bile Acid Synthesis Independent of Fibroblast Growth Factor 19 in Primary Human Hepatocytes
por: Johansson, Helene, et al.
Publicado: (2021)

Chenodeoxycholic Acid-Amikacin Combination Enhances Eradication of Staphylococcus aureus
por: Cui, Kaiyu, et al.
Publicado: (2023)

Osteocalcin attenuates high fat diet-induced impairment of endothelium-dependent relaxation through Akt/eNOS-dependent pathway
por: Dou, Jianxin, et al.
Publicado: (2014)

Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge
por: Zweers, Serge J., et al.
Publicado: (2016)

Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis
por: Gong, Zizhen, et al.
Publicado: (2016)

Patterns of Circulating Fibroblast Growth Factor 21 in Subjects with and without Type 2 Diabetes
por: Lu, Jingyi, et al.
Publicado: (2015)

Cerebrotendinous xanthomatosis‐associated diarrhea and response to chenodeoxycholic acid treatment
por: Brass, Eric P., et al.
Publicado: (2020)

Cerebrotendinous Xanthomatosis: diversity of presentation and refining treatment with chenodeoxycholic acid
por: Islam, Mahjabin, et al.
Publicado: (2021)

Elevated Serum Level of Cytokeratin 18 M65ED Is an Independent Indicator of Cardiometabolic Disorders
por: Qian, Lingling, et al.
Publicado: (2020)

Fasting plasma glucose variability and all-cause mortality among type 2 diabetes patients: a dynamic cohort study in Shanghai, China
por: Xu, Dongli, et al.
Publicado: (2016)

Influence of the gut microbiota on endometriosis: Potential role of chenodeoxycholic acid and its derivatives
por: Li, Yangshuo, et al.
Publicado: (2022)

The Effect of Lowering the Threshold for Diagnosis of Impaired Fasting Glucose
por: Kim, So Hun, et al.
Publicado: (2008)

Lower fasting blood glucose in neurofibromatosis type 1
por: Martins, Aline Stangherlin, et al.
Publicado: (2015)

Visfatin is negatively associated with coronary artery lesions in subjects with impaired fasting glucose
por: Xu, Fei, et al.
Publicado: (2022)

Efficacy of Chenodeoxycholic Acid and Ursodeoxycholic Acid Treatments for Refractory Functional Dyspepsia
por: Jang, Sung Ill, et al.
Publicado: (2022)

Mesh-based Monte Carlo method using fast ray-tracing in Plücker coordinates
por: Fang, Qianqian
Publicado: (2010)

Successful treatment of infantile oxysterol 7α-hydroxylase deficiency with oral chenodeoxycholic acid
por: Tang, Yun-Ping, et al.
Publicado: (2021)

Negative Regulation of DsbA-L Gene Expression by the Transcription Factor Sp1
por: Fang, Qichen, et al.
Publicado: (2014)

Greater variation in affect is associated with lower fasting plasma glucose()
por: Gupta, Sunjai, et al.
Publicado: (2016)

Hepatotoxicity due to chenodeoxycholic acid supplementation in an infant with cerebrotendinous xanthomatosis: implications for treatment
por: Huidekoper, Hidde H., et al.
Publicado: (2015)

The impact of FAST on the research of fast radio bursts
por: Xu, Renxin
Publicado: (2021)

Fasting Ghrelin Levels Are Decreased in Obese Subjects and Are Significantly Related With Insulin Resistance and Body Mass Index
por: Papandreou, Dimitrios, et al.
Publicado: (2017)

Decreased levels of Fibroblast Growth Factor 21 are correlated with improved hypoglycemia in patients with insulinoma
por: Li, Xu, et al.
Publicado: (2017)

Pioglitazone Decreases Fasting and Postprandial Endogenous Glucose Production in Proportion to Decrease in Hepatic Triglyceride Content
por: Ravikumar, Balasubramanian, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_c5sd8obqo494db3ssnjjl98ic5